This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ryvu Therapeutics S.a.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Marek Wronowski - Innovator in Heterocyclic Compounds
Introduction
Marek Wronowski is an inventor based in Poland, recognized for his contributions to the field of medicinal chemistry. His work primarily focuses on the development of heterocyclic compounds that serve as modulators of the Stimulator of Interferon Genes (STING).
Latest Patents
Wronowski holds a patent titled "Heterocyclic Compounds As Modulators Of Stimulator Of Interferon Genes." This invention relates to compounds of formula (I) and their various forms, including salts, stereoisomers, tautomers, or N-oxides. These compounds are significant for their potential use as modulators of STING, which plays a crucial role in immune response. The patent also discusses the application of these compounds as medicaments and their inclusion in pharmaceutical compositions.
Career Highlights
Throughout his career, Marek Wronowski has focused on innovative approaches to drug development. His research has contributed to the understanding of how specific compounds can influence immune pathways, paving the way for new therapeutic strategies.
Conclusion
Marek Wronowski's work in the field of heterocyclic compounds highlights the importance of innovation in medicinal chemistry. His contributions may lead to significant advancements in the treatment of various diseases through the modulation of immune responses.